• Home
  • Explore Resources
    • Clinical
    • Scientific
    • Regulatory
    • Regulatory Links
  • Spotlight Topics
    • Potency Matters
    • Key Characteristics
  • About Us
  • Home
  • Explore Resources
    • Clinical
    • Scientific
    • Regulatory
    • Regulatory Links
  • Spotlight Topics
    • Potency Matters
    • Key Characteristics
  • About Us
  • Home
  • Explore Resources
    • Clinical
    • Scientific
    • Regulatory
    • Regulatory Links
  • Spotlight Topics
    • Potency Matters
    • Key Characteristics
  • About Us

Kinetically-derived maximal dose (KMD) confirms lack of human relevance for high-dose effects of octamethylcylotetrasiloxane (D4)

by Susan Borgert | Aug 6, 2025 | Publications

Beyond key characteristics of carcinogens: an archetypal MOA-based evidence system for hypothesis testing to advance carcinogen risk assessment

by Susan Borgert | Aug 6, 2025 | Publications

Avoiding a reproducibility crisis in regulatory toxicology—on the fundamental role of ring trials

by Susan Borgert | Aug 6, 2025 | Publications

Video: Mission of the Endocrine Policy Forum

Video: Mission of the Endocrine Policy Forum

by Michael Boyd | Jul 25, 2023 | Videos

01 QnA – Answering Clinician Questions with Evidence Based Science

01 QnA – Answering Clinician Questions with Evidence Based Science

by Michael Boyd | Jul 25, 2023 | Pamphlets

« Older Entries

Recent Posts

  • Endocrine Policy Forum website created

Recent Comments

    Archives

    • October 2017

    Categories

    • Issue Analysis
    • Pamphlets
    • Presentations
    • Publications
    • Spotlight Topic
    • Uncategorized
    • Videos

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Contact Us

    The EPF welcomes your input and questions.